July 22 Quick Takes: Anocca’s $47M B round to support Swedish biotech’s T cell pipeline

In Sweden’s largest biotech venture round of the year, Anocca AB raised $47 million in a series B round to advance the company’s cellular biology technology and pipeline of TCR-modified T cell therapies. Danske Bank led the offering, which had participation from Swedbank Robur Ny Teknik, Ramsbury Invest and family offices including those of Harald Mix and Robert Andreen and existing investors including Mellby Gård, Nidoco and co-founder Mikael Blomqvist via Michano. The company has now raised more than $100 million.

Northpond Ventures led a $23 million series A round for Slingshot Biosciences that will enable the Emeryville, Calif.-based company to expedite the commercialization of its synthetic cell products, which include controls, diagnostics and adoptive cell therapies. Arch Venture Partners and Anterra Capital also participated in the financing for the company, which has operated under the radar since 2012...